These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 38046417)

  • 1. Progress in the clinical treatment of keloids.
    Qi W; Xiao X; Tong J; Guo N
    Front Med (Lausanne); 2023; 10():1284109. PubMed ID: 38046417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Communication from Immune Cells to the Fibroblasts in Keloids: Implications for Immunotherapy.
    Zhang X; Wu X; Li D
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSP1 promotes fibroblast proliferation and extracellular matrix deposition via the IL6/JAK2/STAT3 signalling pathway in keloids.
    Feng QL; Gu JJ; Chen JY; Zheng WY; Pan HH; Xu XY; Deng CC; Yang B
    Exp Dermatol; 2022 Oct; 31(10):1533-1542. PubMed ID: 35661430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keloids--clinical diagnosis, pathogenesis, and treatment options.
    Marneros AG; Krieg T
    J Dtsch Dermatol Ges; 2004 Nov; 2(11):905-13. PubMed ID: 16281608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic and keloid scars fail to progress from the CD34
    Limandjaja GC; Belien JM; Scheper RJ; Niessen FB; Gibbs S
    Br J Dermatol; 2020 Apr; 182(4):974-986. PubMed ID: 31206605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
    Ogawa R; Akaishi S
    Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keloids: The paradigm of skin fibrosis - Pathomechanisms and treatment.
    Andrews JP; Marttala J; Macarak E; Rosenbloom J; Uitto J
    Matrix Biol; 2016 Apr; 51():37-46. PubMed ID: 26844756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keloids: a review of therapeutic management.
    Ekstein SF; Wyles SP; Moran SL; Meves A
    Int J Dermatol; 2021 Jun; 60(6):661-671. PubMed ID: 32905614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin A for the treatment of keloids.
    Gauglitz GG; Bureik D; Dombrowski Y; Pavicic T; Ruzicka T; Schauber J
    Skin Pharmacol Physiol; 2012; 25(6):313-8. PubMed ID: 22948093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of keloids through Runx2 siRNA‑induced inhibition of the PI3K/AKT signaling pathway.
    Lv W; Wu M; Ren Y; Luo X; Hu W; Zhang Q; Wu Y
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications of basic research that shows reducing skin tension could prevent and treat abnormal scarring: the importance of fascial/subcutaneous tensile reduction sutures and flap surgery for keloid and hypertrophic scar reconstruction.
    Ogawa R; Akaishi S; Huang C; Dohi T; Aoki M; Omori Y; Koike S; Kobe K; Akimoto M; Hyakusoku H
    J Nippon Med Sch; 2011; 78(2):68-76. PubMed ID: 21551963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomechanical Regulatory Factors and Therapeutic Targets in Keloid Fibrosis.
    Feng F; Liu M; Pan L; Wu J; Wang C; Yang L; Liu W; Xu W; Lei M
    Front Pharmacol; 2022; 13():906212. PubMed ID: 35614943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside Rg3 inhibits keloid fibroblast proliferation, angiogenesis and collagen synthesis in vitro via the TGF‑β/Smad and ERK signaling pathways.
    Tang M; Bian W; Cheng L; Zhang L; Jin R; Wang W; Zhang Y
    Int J Mol Med; 2018 Mar; 41(3):1487-1499. PubMed ID: 29328420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPARC promotes fibroblast proliferation, migration, and collagen production in keloids by inactivation of p53.
    Shi S; Li Q; Liu Y; Zhang R; Chen H
    J Dermatol Sci; 2023 Jan; 109(1):2-11. PubMed ID: 36642579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin Is Involved in Connective Tissue Growth Factor-Induced Proliferation, Migration and Overproduction of the Extracellular Matrix in Keloid Fibroblasts.
    Luo L; Li J; Liu H; Jian X; Zou Q; Zhao Q; Le Q; Chen H; Gao X; He C
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28498357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes from human adipose-derived mesenchymal stem cells inhibit production of extracellular matrix in keloid fibroblasts via downregulating transforming growth factor-β2 and Notch-1 expression.
    Li J; Li Z; Wang S; Bi J; Huo R
    Bioengineered; 2022 Apr; 13(4):8515-8525. PubMed ID: 35333672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Keloid by Implantation of Tissue Expander beneath the Keloid Tissue.
    Ali A; Xiao-Dong C
    Mymensingh Med J; 2021 Jul; 30(3):816-825. PubMed ID: 34226473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures.
    Abergel RP; Pizzurro D; Meeker CA; Lask G; Matsuoka LY; Minor RR; Chu ML; Uitto J
    J Invest Dermatol; 1985 May; 84(5):384-90. PubMed ID: 3998489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wide spread scars, hypertrophic scars, and keloids.
    Rudolph R
    Clin Plast Surg; 1987 Apr; 14(2):253-60. PubMed ID: 3581659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of inter- and intra-keloid heterogeneity through analysis of dermal fibroblasts: A new insight in deciphering keloid physiopathology.
    Serror K; Ferrero L; Boismal F; Sintes M; Thery M; Vianay B; Henry E; Gentien D; DE LA Grange P; Boccara D; Mimoun M; Bouaziz JD; Benssussan A; Michel L
    Exp Dermatol; 2023 Jul; 32(7):1096-1107. PubMed ID: 37148203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.